An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

Clinical trial NCT07217860 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07217860
Sponsor: Xenon Pharmaceuticals Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Depression Bipolar I Disorder Bipolar Disorder Bipolar II Disorder

Start date: 2025-10-30
Primary completion: 2029-06-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.